GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trellus Health PLC (LSE:TRLS) » Definitions » 3-Year Dividend Growth Rate

Trellus Health (LSE:TRLS) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trellus Health 3-Year Dividend Growth Rate?

Trellus Health's Dividends per Share for the six months ended in Jun. 2024 was £0.00.

The historical rank and industry rank for Trellus Health's 3-Year Dividend Growth Rate or its related term are showing as below:

LSE:TRLS's 3-Year Dividend Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.1
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Trellus Health's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Trellus Health's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Trellus Health's 3-Year Dividend Growth Rate

For the Health Information Services subindustry, Trellus Health's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trellus Health's 3-Year Dividend Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Trellus Health's 3-Year Dividend Growth Rate falls into.


;
;

Trellus Health 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Trellus Health  (LSE:TRLS) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Trellus Health's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ -0.016
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trellus Health 3-Year Dividend Growth Rate Related Terms>


Trellus Health Business Description

Traded in Other Exchanges
N/A
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Trellus Health Headlines

No Headlines